|
EDITORIAL BOARD
Chairmen
• James O. Armitage, University of Nebraska Medical Center, Omaha, US
• Manuela Bergmann, Ulm University Hospital, Comprehensive Cancer Center Ulm, Germany
• Franco Cavalli, European School of Oncology (ESO) and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
• Stephan Stilgenbauer, Ulm University Hospital, Germany
Scientific Directors
• Bertrand Coiffier, Centre Hospitalier Lyon Sud, Pierre Bénite, France
• Andreas Engert, University Clinic Cologne, Cologne, Germany
• Massimo Federico, Università di Modena e Reggio Emilia, Modena, Italy
• Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
• Randy Gascoyne, B.C. Cancer Agency, Vancouver, Canada
• Mary Gospodarowicz, Princess Margaret Hospital - University of Toronto, Toronto, Canada
• Anton Hagenbeek, University of Amsterdam - Academic Medical Centre, Amsterdam, The Netherlands
• T. Andrew Lister, St. Bartholomew's Hospital, London, United Kingdom
• Julie M. Vose, University of Nebraska Medical Center, Omaha, US
• Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Conceptual Development and Organisation
• Marcel Sailer, Soon Systems GmbH, Ulm, Germany
• Chatrina Melcher, ESO, Bellinzona, Switzerland
• Dolores Knupfer, ESO, Bellinzona, Switzerland
|
